Tuesday, 10 December 2019

India to soon decide on FDI policy in pharma

13 August 2013 | News | By BioSpectrum Bureau

Once the policy is approved, proposals that were kept in abeyance by the Foreign Investment Promotion Board (FIPB) would move forward.

Once the policy is approved, proposals that were kept in abeyance by the Foreign Investment Promotion Board (FIPB) would move forward.

Singapore: Ahead of the raging issue of Foreign Direct Investment (FDI) in the pharmaceutical sector in India, the country's finance minister P chadambaram has said that the government would soon finalise the policy.

He said that the government is looking into the matter and will soon finalise the foreign investment policy on brownfield pharmaceutical projects in the country to pave the way for clearance of held up proposals. He added that the Ministry of Commerce and the Prime Minister would be holding the final discussion on the issue in a day of two.

Once the policy is approved, proposals that were kept in abeyance by the Foreign Investment Promotion Board (FIPB) would move forward.

Currently the country permits 100 percent FDI in the pharmaceutical sector through the automatic approval route in new projects, while foreign investment in existing pharmaceutical companies is allowed only with the FIPB's approval.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls